Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxcarbazepine Monotherapy in Children With Partial Seizures
NCT00275912Phase 4Completed
- Sponsor
- Novartis
- Start
- Sep 2006
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oxcarbazepine in epilepsy, sponsored by Novartis. Primary endpoints: Epileptic activity at electroencephalography in rest, Flash light and hyperventilation test with electroencephalography and 3 more. Started Sep 2006; status: completed.
02
Drugs
oxcarbazepine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00275912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00275912.